Regarding the pharmacological treatment (Table 5), at baseline, patients with early nephropathy significantly used a lower number of antihiypertensive drugs, more angiotensin converting enzyme inhibitors (ACEIs) and less and angiotensin receptor blockers (ARBs) than those with overt nephropathy. Here, ACE is linked to kidney disorder.